Answers are grounded in this paper and cite their sources.
Promoting the thermogenic remodeling of white adipose tissue (WAT) is a promising strategy to combat obesity. Lipophagy-mediated lipid droplet degradation provides free fatty acids to fuel thermogenesis in beige adipocytes, yet the regulatory mechanisms that link lipophagy to adaptive thermogenesis remain largely unknown. Here, we identify GDP dissociation inhibitor 2 (GDI2) as a previously unrecognized negative regulator of WAT browning and adaptive thermogenesis. GDI2 expression was positively correlated with BMI in humans and was upregulated in the adipose tissue of obese mice, but was downregulated by cold exposure. Adipocyte-specific deletion of Gdi2 in mice promoted cold-induced WAT browning and energy expenditure, and conferred resistance to diet-induced obesity, insulin resistance, and hepatic steatosis. Mechanistically, GDI2 acted as a molecular brake on lipophagy by inhibiting Rab7-dependent late-stage autophagosome-lysosome fusion, independent of the canonical neutral lipolysis pathway. Gdi2 deficiency releases this brake, accelerating the lipophagic degradation of LDs and thereby increasing the supply of free fatty acids. These fatty acids serve as signaling ligands to activate a PPARα-dependent thermogenic program, accompanied by coordinated upregulation of oxidative phosphorylation genes, thereby directing lipid flux toward energy dissipation. Collectively, our findings establish GDI2 as a key inhibitor of adipocyte lipophagy that restrains beige fat thermogenesis, positioning GDI2 as a potential therapeutic target to combat obesity and related metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: